Amneal Pharmaceuticals Future Growth
How is Amneal Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AMRX's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if AMRX's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if AMRX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMRX's revenue (4% per year) is forecast to grow slower than the US market (7.1% per year).
High Growth Revenue: AMRX's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMRX's Return on Equity is forecast to be very high in 3 years time (45.6%).